Oramed Pharmaceuticals Inc. (TLV:ORMP)
Israel
· Delayed Price · Currency is ILS · Price in ILA 712.00
+3.50 (0.49%)
Aug 14, 2025, 5:24 PM IDT
Oramed Pharmaceuticals Market Cap
Oramed Pharmaceuticals has a market cap or net worth of 293.06 million as of August 14, 2025. Its market cap has decreased by -23.05% in one year.
Market Cap
293.06M
Enterprise Value
-151.18M
Revenue
7.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
712.00
Market Cap Chart
Since March 19, 2004, Oramed Pharmaceuticals's market cap has increased from 2.37M to 293.06M, an increase of 12,258.52%. That is a compound annual growth rate of 25.22%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 65.08B |
| Danel (Adir Yeoshua) | 2.52B |
| Kamada | 1.46B |
| Bait Bakfar | 1.06B |
| SofWave Medical | 980.58M |
| BrainsWay | 788.58M |
| Novolog (Pharm-Up 1966) | 709.61M |
| Ilex Medical | 671.29M |